João Borges - Concepedia

Author

João Borges

Also Known As

J Borges, J. Borges, J. L. C. BORGES, J. L. C. Borges, J. L. Cunha Borges, JOAO L. C. BORGES, JOAO LINDOLFO BORGES, JOÃO L. C. BORGES, Jeneffer Ferreira Borges, Joao Borges

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Universidade Católica de Brasília Stanford University University of Virginia Center for Clinical Research (United States)University of Toronto

About

João Borges is an author at Universidade Católica de Brasília specializing in medicine, physiology, and chronic kidney disease.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	1.5K
2	Diabetes	2	2	1.2K
3	Health Sciences	1	1	10
4	Public Health	1	1	34
5	Applied Physiology	1	1	10

João Borges

Publications

Citations

H-Index

Page 1

	Year	Citations
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress, The Lancet UrologyRenal DiseaseRenal EventsRenal FunctionDiabetes	2019	589
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial Stefano Del Prato, Steven E. Kahn, Imre Pávó, The Lancet Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseMedicineInsulin Management	2021	586
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial Jordi Díaz‐Manera, Priya S. Kishnani, Hani Kushlaf, The Lancet Neurology Late-onset Pompe DiseaseAutoimmune DiseaseClinical Infectious DiseaseMedicinePhase 3	2021	169
Effect of SGLT2 Inhibitors on Stroke and Atrial Fibrillation in Diabetic Kidney Disease Zien Zhou, Meg Jardine, Qiang Li, Stroke	2021	111
A randomized, parallel group, double‐blind, multicentre study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long‐term glycaemic control and bone mineral density after 80 weeks of treatment in drug‐na <i>ï</i> ve type 2 diabetes mellitus patients João Borges, John P. Bilezikian, Angela R. Jones-Leone, Diabetes Obesity and Metabolism	2011	88
Retrievable Metal Ceramic Implant‐Supported Fixed Prostheses with Milled Titanium Frameworks and All‐Ceramic Crowns: Retrospective Clinical Study with up to 10 Years of Follow‐Up Paulo Maló, Miguel de Araújo Nobre, João Borges, Journal of Prosthodontics	2012	83
Effects of Intravenous, Subcutaneous, and Intranasal Administration of Growth Hormone (GH)-Releasing Hormone-40 on Serum GH Concentrations in Normal Men* William S. Evans, Mary Lee Vance, Donald L. Kaiser, The Journal of Clinical Endocrinology & Metabolism	1985	60
Effects of Human Pancreatic Growth Hormone-Releasing Factor-40 on Serum Growth Hormone, Prolactin, Luteinizing Hormone, Follicle-Stimulating Hormone, and Somatomedin-C Concentrations in Normal Women throughout the Menstrual Cycle* William S. Evans, João Borges, Mary Lee Vance, The Journal of Clinical Endocrinology & Metabolism Human GrowthGynecologyPathologySerum Growth HormoneFemale Reproductive Function	1984	58
INTRANASAL ADMINISTRATION OF HUMAN PANCREATIC TUMOR GH-RELEASING FACTOR-40 STIMULATES GH RELEASE IN NORMAL MEN William S. Evans, João Borges, Donald L. Kaiser, The Journal of Clinical Endocrinology & Metabolism	1983	43
Biphasic Luteinizing Hormone Secretion in Response to Gonadotropin-Releasing Hormone during Continuous Perifusion of Dispersed Rat Anterior Pituitary Cells: Changes in Total Release and the Phasic Components during the Estrous Cycle* William S. Evans, BEVERLY J. BOYKIN, Donald L. Kaiser, Endocrinology FertilityHuman GrowthComparative EndocrinologyGnrh InfusionGynecology	1983	34

Page 1